JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DAYRIT, C.
Right arrow Articles by SEEVERS, M. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DAYRIT, C.
Right arrow Articles by SEEVERS, M. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 92, Issue 2, 173-186, 1948
Copyright © 1948 by American Society for Pharmacology and Experimental Therapeutics


ON THE PHARMACOLOGY OF HEXAETHYL TETRAPHOSPHATE

CONRADO DAYRIT 1, CLAYTON H. MANRY 1, and M. H. SEEVERS 1

1 Department of Pharmacology, University of Michigan Medical School, Ann Arbor

The pharmacologic actions and toxicity of HETP were studies in rabbits, mice and in intact and anesthetized dogs.

HETP produces muscarinic and nicotinic effects of relatively brief duration. That the action is more lasting than these brief observable signs would suggest is shown by the cumulative effects of repeated injections.

The lethal action of toxic doses of HETP in unprotected animals is exerted within 15-30 minutes by intravenous injection, and within 1-2 hours by the intramuscular route. Animals that survive these periods eventually recover.

Death is due to respiratory failure from marked bronchoconstriction and increased bronchial secretion. After atropinization, the respiratory failure results probably from direct central depression or the curariform action of acetylcholine.

Atropine is an effective antagonist of the muscarinic effects of HETP and offers protection against approximately three lethal doses of the drug.

HETP has a potent anticholinesterase action which is responsible for most of the effects of the drug.

In vitro, the inhibition of cholinesterase appears to be mainly irreversible, although the in vivo evidence indicates that there is a fairly significant labile component which allows the liberation of sufficient cholinesterase to enable the animal to recover within a short time. HETP, therefore, occupies a position midway between DFP and prostigmine.

The differences between the actions of HETP and DFP were discussed.

Submitted on October 3, 1947




This article has been cited by other articles:


Home page
Toxicol SciHome page
N. Allon, I. Rabinovitz, E. Manistersky, B. A. Weissman, and E. Grauer
Acute and Long-Lasting Cardiac Changes Following a Single Whole-Body Exposure to Sarin Vapor in Rats
Toxicol. Sci., October 1, 2005; 87(2): 385 - 390.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1948 by the American Society for Pharmacology and Experimental Therapeutics.